Researchers from the Mayo Clinic, a specialist cancer research hospital in the USA, have shown that patients taking statins before a stroke experienced better outcomes and recovery than those who were not, even when their cholesterol levels were ideal.
Statins are widely used to improve cardiovascular health and, more recently, for certain vascular conditions in the brain. One use has been to lower the level of low-density lipoprotein which can contribute to arterial blockages.
The findings, reported in the February issue of the Journal of Stroke and Cerebrovascular Diseases, are from an assessment of 508 patients who were diagnosed with acute ischemic stroke in the emergency department during the 22 months from March 2004 to December 2005. Among them, 207 had their lipid levels measured within 15 days either side of the stroke and had LDL levels at or under 100mg/dL, which is considered optimal for healthy individuals.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze